With a declaration by the SEC that the registration statement filed by Scivac Therapeutics Inc. on its proposed merger with VBI Vaccines Inc. was effective, the companies are moving to complete the deal, expected early next month after VBI stockholders meet on May 5 to vote on the transaction.